Shapewear Market (By Distribution Channel: Hypermarkets & Supermarkets, Specialty Stores, Online, Others; By End-user: Male, Female) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Shapewear Market, By Biopsy End-user

7.1.  Shapewear Market, by Biopsy End-user, 2021-2030

7.1.1.    Male

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Female

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Shapewear Market, By Distribution Channel

8.1.  Shapewear Market, by Distribution Channel, 2021-2030

8.1.1.    Hypermarkets & Supermarkets

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Specialty Stores

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Online

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Others

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Shapewear Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.1.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.2.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.3.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.4.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.5.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Biopsy End-user (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 10.  Company Profiles

10.1.              Nike, Inc.

10.1.1.  Company Overview

10.1.2.  Biopsy End-user Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Adidas AG

10.2.1.  Company Overview

10.2.2.  Biopsy End-user Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Spanx Inc.

10.3.1.  Company Overview

10.3.2.  Biopsy End-user Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Triumph International Corporation

10.4.1.  Company Overview

10.4.2.  Biopsy End-user Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Leonisa

10.5.1.  Company Overview

10.5.2.  Biopsy End-user Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Wacoal America, Inc.

10.6.1.  Company Overview

10.6.2.  Biopsy End-user Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Ann Chery

10.7.1.  Company Overview

10.7.2.  Biopsy End-user Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              2XU Pty. Ltd.

10.8.1.  Company Overview

10.8.2.  Biopsy End-user Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Under Armour Inc.

10.9.1.  Company Overview

10.9.2.  Biopsy End-user Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Skins International Trading AG

10.10.1.               Company Overview

10.10.2.               Biopsy End-user Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms